The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

We have investigated the relation between nocturnal insulin requirements and nocturnal growth hormone (GH) release in 26 diabetic adolescents at various puberty stages and have examined the effect of nocturnal GH suppression on pre-breakfast insulin requirement. In all the studies, euglycaemia was m...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Edge, J, Matthews, DR, Dunger, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	1990

Documenti analoghi

Increased overnight growth hormone concentrations in diabetic compared with normal adolescents.
di: Edge, J, et al.
Pubblicazione: (1990)

Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.
di: Edge, J, et al.
Pubblicazione: (1993)

Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes.
di: Edge, J, et al.
Pubblicazione: (1990)

Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
di: Edge, J, et al.
Pubblicazione: (1989)

Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty.
di: Dunger, D, et al.
Pubblicazione: (1991)

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
di: Dunger, D, et al.
Pubblicazione: (1991)

The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
di: Foot, AB, et al.
Pubblicazione: (1990)

An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents.
di: Matthews, DR, et al.
Pubblicazione: (1990)

The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
di: Pal, B, et al.
Pubblicazione: (1993)

The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
di: Cheetham, T, et al.
Pubblicazione: (1994)

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
di: Massoud, A, et al.
Pubblicazione: (1996)

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus.
di: Cheetham, T, et al.
Pubblicazione: (1993)

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
di: A. V. Vitebskaya, et al.
Pubblicazione: (2021-11-01)

The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
di: Cheetham, T, et al.
Pubblicazione: (1997)

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
di: Mullis, P, et al.
Pubblicazione: (1992)

Growth Hormone-Releasing Hormone in Diabetes
di: Leonid Evsey Fridlyand, et al.
Pubblicazione: (2016-10-01)

Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
di: Pal, B, et al.
Pubblicazione: (1992)

Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
di: Dunger, D, et al.
Pubblicazione: (1993)

Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
di: Dunger, D, et al.
Pubblicazione: (1993)

The correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus
di: Roman Gabriela, et al.
Pubblicazione: (2016-03-01)

The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers.
di: Anderson, I, et al.
Pubblicazione: (1989)

THE OVERNIGHT CONSULTANT /
di: Lewin, Marsha D. 242587
Pubblicazione: (1995)

Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
di: Amin, R, et al.
Pubblicazione: (2005)

The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH)
di: Suri, D, et al.
Pubblicazione: (1991)

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
di: Hindmarsh, P, et al.
Pubblicazione: (1991)

Growth-hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release.
di: Grossman, A, et al.
Pubblicazione: (1983)

Growth hormone releasing hormone.
di: Grossman, A, et al.
Pubblicazione: (1986)

Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph.
di: Brain, C, et al.
Pubblicazione: (1988)

Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus
di: Wen Wu, et al.
Pubblicazione: (2017-01-01)

THE CHARACTERISTICS OF GROWTH-HORMONE (GH) PULSATILITY IN NEONATES
di: Adcock, C, et al.
Pubblicazione: (1994)

The effect of prolonged fasting on levels of growth hormone-binding protein and free growth hormone.
di: Salgin, B, et al.
Pubblicazione: (2012)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
di: Korbonits, M, et al.
Pubblicazione: (1998)

Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
di: Ross, R, et al.
Pubblicazione: (1987)

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
di: Looij, B, et al.
Pubblicazione: (1986)

The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
di: Achermann, J, et al.
Pubblicazione: (1999)

A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring
di: Souptik Barua, et al.
Pubblicazione: (2024-02-01)

The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
di: Spoudeas, H, et al.
Pubblicazione: (1992)

GROWTH HORMONE-RELEASING HORMONE-TREATMENT OF GROWTH-HORMONE DEFICIENT CHILDREN
di: Ross, R, et al.
Pubblicazione: (1986)

Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study.
di: Peyrot, M, et al.
Pubblicazione: (2006)

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
di: Besser, G, et al.
Pubblicazione: (1983)